bioAffinity Technologies, Inc. — Director's Dealing 2024

Mar 29, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: bioAffinity Technologies, Inc. (BIAF)
CIK: 0001712762
Period of Report: 2024-02-16

Reporting Person: GIRGENTI STEVEN (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-16	Common Stock	A	39474	$1.52	Acquired	991758	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	8955	Indirect

Footnotes

F1: Grant of restricted shares, which shares will vest in full on February 16, 2027, the third anniversary of the grant date.

F2: These shares owned directly by the Cranye Girgenti Testamentary Trust (the "Trust"). The reporting person is a co-trustee of the Trust. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.